Inventiva S.A. 0RNK.L Stock
Inventiva S.A. Price Chart
Inventiva S.A. 0RNK.L Financial and Trading Overview
| Inventiva S.A. stock price | 3.56 EUR |
| Previous Close | 3.95 EUR |
| Open | 4.1 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 4.1 - 4.24 EUR |
| 52 Week Range | 1.92 - 8.08 EUR |
| Volume | 3.96K EUR |
| Avg. Volume | 15.16K EUR |
| Market Cap | 784.22K EUR |
| Beta (5Y Monthly) | 1.170986 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.267 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0RNK.L Valuation Measures
| Enterprise Value | 93.46M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.04168279 |
| Price/Book (mrq) | 3.8194442 |
| Enterprise Value/Revenue | 4.968 |
| Enterprise Value/EBITDA | -1.66 |
Trading Information
Inventiva S.A. Stock Price History
| Beta (5Y Monthly) | 1.170986 |
| 52-Week Change | -43.23% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.08 EUR |
| 52 Week Low | 1.92 EUR |
| 50-Day Moving Average | 2.74 EUR |
| 200-Day Moving Average | 4.31 EUR |
0RNK.L Share Statistics
| Avg. Volume (3 month) | 15.16K EUR |
| Avg. Daily Volume (10-Days) | 29.48K EUR |
| Shares Outstanding | 22.26M |
| Float | 11.66M |
| Short Ratio | N/A |
| % Held by Insiders | 25.11% |
| % Held by Institutions | 47.22% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -288.47% |
| Operating Margin (ttm) | -303.80% |
| Gross Margin | 94.71% |
| EBITDA Margin | -299.31% |
Management Effectiveness
| Return on Assets (ttm) | -30.020% |
| Return on Equity (ttm) | -80.80% |
Income Statement
| Revenue (ttm) | 18.81M EUR |
| Revenue Per Share (ttm) | 0.45 EUR |
| Quarterly Revenue Growth (yoy) | 142.79% |
| Gross Profit (ttm) | 18.81M EUR |
| EBITDA | -56314000 EUR |
| Net Income Avi to Common (ttm) | -54274000 EUR |
| Diluted EPS (ttm) | -1.267 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 87.02M EUR |
| Total Cash Per Share (mrq) | 2.07 EUR |
| Total Debt (mrq) | 44.39M EUR |
| Total Debt/Equity (mrq) | 97.61 EUR |
| Current Ratio (mrq) | 3.465 |
| Book Value Per Share (mrq) | 1.08 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -44928000 EUR |
| Levered Free Cash Flow (ttm) | -20659624 EUR |
Profile of Inventiva S.A.
| Country | United Kingdom |
| State | N/A |
| City | Daix |
| Address | 50 rue de Dijon |
| ZIP | 21121 |
| Phone | 33 3 80 44 75 00 |
| Website | https://www.inventivapharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 109 |
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
Q&A For Inventiva S.A. Stock
What is a current 0RNK.L stock price?
Inventiva S.A. 0RNK.L stock price today per share is 3.56 EUR.
How to purchase Inventiva S.A. stock?
You can buy 0RNK.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Inventiva S.A.?
The stock symbol or ticker of Inventiva S.A. is 0RNK.L.
How many shares does Inventiva S.A. have in circulation?
The max supply of Inventiva S.A. shares is 190.11K.
What is Inventiva S.A. Price to Earnings Ratio (PE Ratio)?
Inventiva S.A. PE Ratio is now.
What was Inventiva S.A. earnings per share over the trailing 12 months (TTM)?
Inventiva S.A. EPS is -1.267 EUR over the trailing 12 months.